Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02895867 · ClinicalTrials.gov registry record · NA

Effect of Dairy Consumption on Glycemic Control, Body Weight and Cardiovascular Risk in Patients With Type 2 Diabetes

A NA study of Type 2 Diabetes, sponsored by Joslin Diabetes Center.

Completed
Registry status
NA
Development phase
112
Enrollment target
1
Study location

NCT02895867 is a NA study of Type 2 Diabetes that has completed, run by Joslin Diabetes Center. The registered enrollment target is 112 participants, below the 1,102-participant average among 288 other Type 2 Diabetes trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02895867, a NA study of Type 2 Diabetes, has completed, sponsored by Joslin Diabetes Center.

COMPLETED
Registry status
NA
Development phase
112 participants
Enrollment target
1
Study location

Study Summary

This is a randomized prospective clinical study in patients with type 2 diabetes to evaluate the effect of dairy products with full or low fat on glycemic control and cardio-metabolic risk factors in comparison to a regular diet.

Conditions Studied

Interventions

  • OTHER Control
  • OTHER Full fat dairy
  • OTHER Low fat dairy

Study Locations (1)

Massachusetts

  • Joslin Diabetes Center - Boston

Trial Details

FieldValue
Enrollment Target 112 participants
Start Date 2016-05
Est. Completion 2018-08
Phase NA

Sponsor

Joslin Diabetes Center

73 total trials

What the Registry Record Tells You About NCT02895867

The ClinicalTrials.gov registry entry for NCT02895867 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 112 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,102-participant average among 288 other Type 2 Diabetes trials with a reported enrollment target (90% lower). The listed sponsor is Joslin Diabetes Center, which has 73 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Type 2 Diabetes appearing as the primary indexed condition, and to 3 interventions - of which Control is the first listed.

NCT02895867 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT02895867 about?

NCT02895867 is a clinical study titled "Effect of Dairy Consumption on Glycemic Control, Body Weight and Cardiovascular Risk in Patients With Type 2 Diabetes". This is a randomized prospective clinical study in patients with type 2 diabetes to evaluate the effect of dairy products with full or low fat on glycemic control and cardio-metabolic risk factors in comparison to a regular diet.

What is the current status of trial NCT02895867?

This trial is currently completed. It is a NA study. The enrollment target is 112 participants. The study started on 2016-05. Estimated completion is 2018-08.

What conditions does trial NCT02895867 study?

This clinical trial studies the following conditions: Type 2 Diabetes.

What interventions are being tested in trial NCT02895867?

The interventions under investigation include: Control (OTHER), Full fat dairy (OTHER), Low fat dairy (OTHER).

Who is sponsoring clinical trial NCT02895867?

This trial is sponsored by Joslin Diabetes Center, which has 73 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02895867 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Type 2 Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.